Poland· PL-100439840
Aescin
A other capillary stabilizing agents product containing escinum, registered in Poland by PharmaVitae Sp. z o.o. sp. k.. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Escinum is registered in 4 of 19 countries.
Countries holding a registration under ATC C05CX (other capillary stabilizing agents), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Escinum · ATC C05CX
4 / 19 countries
- Belgiumprice
- Czechiaprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Escinum
- Manufacturer
- PharmaVitae Sp. z o.o. sp. k.
- Country
- Poland (PL)
- ATC code
- C05CX
- ATC class
- Other capillary stabilizing agents
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991436810
- gtin05909991436827
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Escinum in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaREPARIL DRAGÉESCooper Consumer Health B.V., Diemen
- BelgiumReparil 20 mgImpexeco
- GermanyReparilCooper Consumer Health Deutschland Gmbh
- SpainFLEBOSTASIN RETARD 50 mg CÁPSULAS DURAS DE LIBERACIÓN PROLONGADAGlenwood Gmbh Pharmazeutische Erzeugnisse
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Austria · Reparil, Venostasin
- Belgium · Reparil
- Bulgaria · Репарил
- Czechia · Aescin Teva, Reparil Dragées
- Germany · Reparil-Dragees, Reparil-Dragees Zur Anwendung Bei Erwachsenen Und Kindern Ab 7 Jahren
- Italy · Edevexin, Reparilexin
- Slovakia · Aescin, Aescin Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5401e9a7-6fa0-4ba6-b019-f61cd752ba76 GET /v1/drugs/5401e9a7-6fa0-4ba6-b019-f61cd752ba76?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki dojelitowe",
"source": "urpl",
"strength": "20 mg",
"packaging": "05909991436810 ¦ OTC ¦ 137313\n30 tabl.\n05909991436827 ¦ OTC ¦ 137314\n90 tabl.",
"substance": "Escinum 20 mg",
"common_name": "Escinum",
"pl_product_id": "100439840",
"pozwolenie_nr": "234/20",
"auth_procedure": "IR",
"authorisation_validity": "2025-09-11"
}See everything about escinum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.